5th Product and Pipeline Enhancement for Generics
17th July 2012 — 19th July 2012

Adopt Innovative Approaches to Strengthen the Product Pipeline and Prepare for Regulatory Changes to Emerge as a Global Player

key conference topics

• Assess the most recent FDA proposals regarding biosimilars development and user fees for generic companies
• Develop key strategies to balance and diversify the company's global portfolio
• Instill more innovative approaches for the drug pipeline to heighten a competitive edge
• Implement techniques to sustain product portfolios and increase the company's bottom line
• Understand regulatory nuances of global markets and how to frame and prepare for potential expansion

key conference features

• Pre-Conference Workshops: July 17, 2012
• Workshop A: Overcoming the Challenges of Global Portfolio Management to Improve Decision-Making
• Workshop B: Forming a Commercial Strategy to Break into the Biosimilars Market
• Conference Chairperson: Richard Dicicco, Chairman at Harvest Moon Pharma

conference focus
The current generics market is experiencing increased competition between the North American global branded and generic pharmaceutical companies. This added competition vastly increases the need for generic pharmaceuticals to create and implement effective patent strategies to succeed in today’s volatile market.

The marcus evans 5th Product and Pipeline Enhancement for Generics Conference will host industry leaders within the Generic Pharmaceutical, Branded Pharmaceutical and API industries operating globally as they share best practices, strategies and tools on portfolio management and business strategy, as well as legal, intellectual property and patent issues.

Attendees will leave this conference with a better understanding of:
1. Current and upcoming FDA proposals and regulations to ensure compliance
2. Innovation in the drug pipeline
3. Portfolio management and business development
4. How to protect the company’s patents’ and intellectual property
5. Expanding the commercial reach through biosimilars
6. Market changes and future industry developments

With a one-track focus, the 5th Product and Pipeline Enhancement for Generics Conference is a highly intensive, content-driven event that includes case studies, presentations and panel discussions over two full days. This conference targets industry leaders from the pharmaceutical, medical device and biotechnology and clinical research organizations in order to provide an intimate atmosphere for both the delegates and speakers.

conference speakers
Richard Dicicco
Chairman
Harvest Moon Pharmaceuticals

Dr. Vijay Soni
Executive Vice President, IP, BD and Product Portfolio
Glenmark Pharmaceuticals

Candis Edwards
Senior Vice President, Regulatory Affairs & Compliance
Amneal Pharmaceuticals

Jeffrey Wasserstein
SVP, Business Development & Strategy
Fougera Pharmaceuticals, Inc., a subsidiary of Nycomed US

Gregory Fernengel, JD, R.Ph.
Senior Intellectual Property Counsel
Ben Venue Laboratories, Inc., A Boehringer Ingelheim Company

Steve Maddox
Partner
Knobbe Martens Olson & Bear LLP

Gopalakrishnan Venkatesan
Associate Vice President, Business Development
Wockhardt USA LLC

Steven E. Feldman
Partner
Husch Blackwell LLC

Vishal K. Gupta
Chief Scientific Officer; Vice President, Research & Development
CorePharma LLC

Carla Vozone
Business Development Director
Hovione

Huong Nguyen
Senior Director, Intellectual Property
Impax Laboratories, Inc.

Patrick Nadeau
Senior Director, Strategic Portfolio Management
Pharmascience

Kevin Nelson
Partner
Locke Lord

Indranil Nandi, Ph.D.
Director, Project Management Portfolio, Project and Launch Management Group
Sandoz Inc.

Sherri Leonard
VP, Business Development and Portfolio Management
OrchidPharma, Inc.

Bill Zimmerman
Partner
Knobbe Martens Olson & Bear LLP

Markus Meier
Assistant Director, Health Care Division
Federal Trade Commission

Karan Arora
Senior Director, Global Corporate Strategy & Development and Proprietary Pharmaceuticals
Hospira

Expected Number of Attendees

MA

View Conference Website: 5th Product and Pipeline Enhancement for Generics

Price of Attendance

N/A

Brochure

View Event Brochure

Location

Washington
Washington
Washington
United States
DC